about
Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native populationCutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells.IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.High prevalence of X4/DM-tropic variants in children and adolescents infected with HIV-1 by vertical transmission.Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007).Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses.HIV-1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA.HIV-1 non-B subtypes: High transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability.Drug resistance prevalence in human immunodeficiency virus type 1 infected pediatric populations in Honduras and El Salvador during 1989-2009.MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection.Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, SpainUtilidad de los dried blood spots para monitorizar la infección por virus de la inmunodeficiencia humana en los programas de salud pública de países en desarrolloTelescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression
P50
Q28477624-11AE26AC-3758-41EE-BF4A-77A1997123B4Q33998437-514697BC-37BF-4C60-9395-6C8C36736FF9Q38720858-8F3A95B9-7041-4C45-904D-E57F4832245DQ38921734-2E03533D-180A-447E-AF01-09F5BFD8A115Q39615541-EFDD08C6-EEEF-426E-ACC3-4EC8D4434343Q41438669-ECC7D6C9-CAD7-4AC6-A010-A98D70FC0DDBQ42263579-9909B677-4306-43E2-894D-741485677015Q43224760-E9D9394C-BF74-4A92-97E1-B587C95B7CBDQ45369011-6889F60D-4B1A-4628-9E69-3F3B5170F78CQ47550378-D4491E97-E23F-4C87-9D92-EE6F46566D89Q56839568-6C3974E7-3AC6-45EC-A316-AA26AA9D26D1Q60227456-78FA8B15-EF92-4AFB-B388-8CBC0F82A96BQ90375354-D51DF397-87AB-4929-A300-E93BD3495CF9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Miguel de Mulder Rougvie
@ast
Miguel de Mulder Rougvie
@en
Miguel de Mulder Rougvie
@es
Miguel de Mulder Rougvie
@nl
type
label
Miguel de Mulder Rougvie
@ast
Miguel de Mulder Rougvie
@en
Miguel de Mulder Rougvie
@es
Miguel de Mulder Rougvie
@nl
prefLabel
Miguel de Mulder Rougvie
@ast
Miguel de Mulder Rougvie
@en
Miguel de Mulder Rougvie
@es
Miguel de Mulder Rougvie
@nl
P108
P106
P108
P21
P31
P496
0000-0002-8026-7076